Skip to Content

Disopyramide Phosphate Controlled-Release Capsules

Last Updated: March 23, 2018
Status: Resolved

Disopyramide Phosphate Controlled-Release Capsules

Products Affected - Description
    • Norpace CR oral extended release capsule, Pfizer, 100 mg, bottle, 500 count, NDC 00025-2732-51
    • Norpace CR oral extended release capsule, Pfizer, 150 mg, bottle, 500 count, NDC 00025-2742-51
Reason for the Shortage
    • Pfizer had disopyramide controlled-release capsules on shortage due to manufacturing delays. The 500 count sizes were discontinued in March 2018.
Available Products
    • Norpace CR oral extended release capsule, Pfizer, 100 mg, bottle, 100 count, NDC 00025-2732-31
    • Norpace CR oral extended release capsule, Pfizer, 150 mg, bottle, 100 count, NDC 00025-2742-31

Estimated Resupply Dates

    • Pfizer has Norpace CR 100 mg capsules in 100 count and 150 mg capsules in 100 count available.

Updated

Updated March 23, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 9, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide